博济医药拟减持不超266.7万股的已回购股份

Core Viewpoint - The company, Boji Pharmaceutical (300404.SZ), announced a plan to repurchase shares through a concentrated bidding method, aiming to maintain company value and shareholder rights [1] Group 1 - The fifth board of directors' nineteenth meeting was held on February 24, 2026, where the share repurchase plan was approved [1] - The company plans to reduce up to 2.667 million shares, which represents 0.69% of the total share capital [1] - The share repurchase is in accordance with the usage terms outlined in the repurchase report disclosed on February 6, 2024 [1]